Obinutuzumab in Active Systemic Lupus Erythematosus. Reply.

Gazyva (obinutuzumab) - Roche, Biogen

Obinutuzumab in Active Systemic Lupus Erythematosus. Reply. (PubMed, N Engl J Med) - Oct 15, 2026 - No abstract available
Journal • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus

http://www.ncbi.nlm.nih.gov/pubmed/42874118

Edward M Vital; Oliver Meier; Richard A Furie

Oct 15, 2026